Drug Delivery · London, United Kingdom · Founded 2021 · Privately Held (backing)
Developer of women-specific drug-delivery systems designed to improve patient outcomes. Calla Lily Clinical Care is based in London, United Kingdom and was founded in 2021. Its last reported valuation was $14.4 million in Jan 2025. It has raised $6.9 million across 1 recorded round; the latest was an accelerator round in Mar 2025.
Last reported valuation
$14.4M
Oct 2026
Priced at
—
Total raised
$6.9M
Last round
Accelerator/Incubator
Mar 2025
Cap table — not yet on record
Calla Lily Clinical Care's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Calla Lily Clinical Care with a free account
·Watch Calla Lily Clinical Care: the Monday email on marks, rounds and moves
Where does Calla Lily Clinical Care's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Calla Lily Clinical Care's 1 recorded funding rounds.
